...
首页> 外文期刊>Bone marrow transplantation >Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated.
【24h】

Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated.

机译:造血SCT(HSCT)后的血流感染(BSI)和急性GVHD相关。

获取原文
获取原文并翻译 | 示例
           

摘要

Blood stream infection (BSI) and acute GVHD (aGVHD) are serious complications of hematopoietic SCT (HSCT). We hypothesized that the two events were not independent of one another. We studied (1) associations between BSI and aGVHD; and (2) the impact of BSI and/or aGVHD on death within 100 days after HSCT, using a retrospective cohort analysis. Risk factor analysis was carried out using multivariable Cox proportional hazards analyses. Of 211 patients who underwent allogeneic HSCT from January 2000 to December 2005 (58% of whom underwent reduced intensity transplantation), 82 (39%) developed BSI. In 49 patients (23%), grade (gr) 2-4 aGVHD occurred. Early BSI was independently associated with an increased occurrence of subsequent aGVHD gr 2-4. CMV seropositivity was independently associated with decreased occurrence of aGVHD. aGVHD gr 2-4 independently predicted subsequent first BSI. Both BSI and aGVHD gr 2-4 were significant independent predictors of death within 100 days after HSCT. There is a strong, independent association between BSI and aGVHD. Potential explanations include the elaboration of cytokines during BSI favoring the development of aGVHD and/or the immunosuppressive treatment of aGVHD favoring the development of BSI. Future studies should be directed at the mechanistic investigations of this association.
机译:血流感染(BSI)和急性GVHD(aGVHD)是造血SCT(HSCT)的严重并发症。我们假设这两个事件不是相互独立的。我们研究了(1)BSI与aGVHD之间的关联; (2)使用回顾性队列分析,BSI和/或aGVHD对HSCT后100天内死亡的影响。使用多变量Cox比例风险分析进行了风险因素分析。在2000年1月至2005年12月接受异基因HSCT的211例患者中(其中58%接受了降低强度的移植),其中82例(39%)发生了BSI。在49例患者中(23%),发生了(gr)2-4 aGVHD。早期BSI独立地与随后的aGVHD gr 2-4发生率增加相关。 CMV血清反应阳性与aGVHD发生率降低独立相关。 aGVHD gr 2-4独立预测随后的第一个BSI。 BSC和aGVHD gr 2-4都是HSCT后100天内死亡的重要独立预测因子。 BSI与aGVHD之间存在牢固的独立关联。可能的解释包括在BSI期间精心制作细胞因子,有利于aGVHD的发展和/或对aGVHD的免疫抑制治疗,有利于BSI的发展。未来的研究应针对该协会的机制研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号